Jiangxi Fushine Pharmaceutical (300497.SZ) obtained GMP certification from the Brazilian National Health Surveillance Agency.
Fusheng Pharmaceutical (300497.SZ) announced that the company has obtained approval from the Brazilian National Health Surveillance Agency (ANVISA)...
Jiangxi Fushine Pharmaceutical (300497.SZ) announced that the company has obtained the Good Manufacturing Practice (GMP) certification certificate for drug production quality management issued by the National Health Surveillance Agency (ANVISA) of Brazil. The certification scope is for the active pharmaceutical ingredient: terbinafine.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
